FGC
UTHR icon

Financial Gravity Companies’s United Therapeutics UTHR Stock Holding History

Financial Gravity Companies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$44K Buy
+379
New +$43.9K 0.04% 374
2018
Q1 		– Sell
-229
Closed -$30K – 1658
2017
Q4 		$30K Buy
+229
New +$29.1K 0.03% 427

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Financial Gravity Companies's UTHR Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in United Therapeutics (UTHR) in Q4 2018: 379 shares worth $44K. The stake represents 0.04% of the portfolio and ranks #374 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in UTHR as recently as Q4 2017.

Financial Gravity Companies first reported a position in UTHR in Q4 2017 and has held it in 2 quarters since. 360 funds tracked by Wall St. Rank hold UTHR as of Q4 2018.

  • Financial Gravity Companies held 379 shares of United Therapeutics worth $44K as of Q4 2018.
  • United Therapeutics was a new Financial Gravity Companies position in Q4 2018.
  • United Therapeutics made up 0.04% of Financial Gravity Companies's portfolio in Q4 2018, its #374 holding.
  • Financial Gravity Companies first reported a position in United Therapeutics in Q4 2017 and has held it in 2 quarters since.
  • 360 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.